Pricing Log in Create free account

Elicio Therapeutics, Inc. (ELTX) vs Hyperion DeFi, Inc. (HYPD)

Elicio Therapeutics, Inc. and Hyperion DeFi, Inc. are both Biotechnology companies. Elicio Therapeutics, Inc. and Hyperion DeFi, Inc. are of similar size ($49.0M and $48.2M). Hyperion DeFi, Inc. grew revenue faster over the last twelve months: 1,990.6% against 921.0%. Elicio Therapeutics, Inc. has the higher net margin (0.00% vs −1,224.5%) and the lower return on invested capital (0.00% vs 2.73%). Across the 17 metrics below, Hyperion DeFi, Inc. leads on 10 and Elicio Therapeutics, Inc. on 7.

Valuation

Metric ELTX HYPD Biotechnology median
P/E n/m n/m 8.50
P/S 1.04 28.74 9.71
P/B 3.78 0.39 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 7.98 0.64
EV/Sales 0.59 27.88 9.21
Earnings yield (139.10%) (217.96%) (33.15%)
Free cash flow yield (125.90%) (191.71%) (25.50%)

Profitability

Metric ELTX HYPD Biotechnology median
Gross margin 0.00% 78.35% 65.16%
Operating margin 0.00% 314.32% 0.00%
Net margin 0.00% (1,224.53%) 0.00%
Free cash flow margin 0.00% (5,509.35%) 0.00%
Return on equity (774.56%) (24.63%) (56.36%)
Return on assets (124.36%) (20.32%) (48.04%)
Return on invested capital 0.00% 2.73% 0.00%

Growth

Metric ELTX HYPD Biotechnology median
Revenue growth (TTM) 921.02% 1,990.60% 6.02%
EPS growth (last fiscal year) 39.29% 84.28% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELTX HYPD Biotechnology median
Debt to equity 1.20 0.08 0.00
Current ratio 2.77 2.34 4.72
Net debt to EBITDA 0.25 (0.03) 0.96

Dividend

Metric ELTX HYPD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ELTX HYPD Biotechnology median
Market cap 48.22m 48.95m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack